BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 12898324)

  • 1. The biochemical and biological functions of human papillomavirus type 16 E5 protein.
    Tsai TC; Chen SL
    Arch Virol; 2003 Aug; 148(8):1445-53. PubMed ID: 12898324
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The HPV16 E5 protein: expression, detection, and stable complex formation with transmembrane proteins in COS cells.
    Hwang ES; Nottoli T; Dimaio D
    Virology; 1995 Aug; 211(1):227-33. PubMed ID: 7645215
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of human papillomavirus 16 E5 to the 16 kDa subunit c (proteolipid) of the vacuolar H+-ATPase can be dissociated from the E5-mediated epidermal growth factor receptor overactivation.
    Rodríguez MI; Finbow ME; Alonso A
    Oncogene; 2000 Aug; 19(33):3727-32. PubMed ID: 10949926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human papillomavirus type 16 E5 gene stimulates the transforming activity of the epidermal growth factor receptor.
    Pim D; Collins M; Banks L
    Oncogene; 1992 Jan; 7(1):27-32. PubMed ID: 1311063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Human papillomavirus type 16 E5 oncoprotein as a new target for cervical cancer treatment.
    Kim MK; Kim HS; Kim SH; Oh JM; Han JY; Lim JM; Juhnn YS; Song YS
    Biochem Pharmacol; 2010 Dec; 80(12):1930-5. PubMed ID: 20643111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Down-regulation of MHC class I by bovine papillomavirus E5 oncoproteins.
    Ashrafi GH; Tsirimonaki E; Marchetti B; O'Brien PM; Sibbet GJ; Andrew L; Campo MS
    Oncogene; 2002 Jan; 21(2):248-59. PubMed ID: 11803468
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of cell transformation by papillomavirus E5 proteins.
    DiMaio D; Mattoon D
    Oncogene; 2001 Nov; 20(54):7866-73. PubMed ID: 11753669
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mutagenic analysis of the E5 protein of human papillomavirus type 16 reveals that E5 binding to the vacuolar H+-ATPase is not sufficient for biological activity, using mammalian and yeast expression systems.
    Adam JL; Briggs MW; McCance DJ
    Virology; 2000 Jul; 272(2):315-25. PubMed ID: 10873774
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The E5 protein of the human papillomavirus type 16 modulates composition and dynamics of membrane lipids in keratinocytes.
    Bravo IG; Crusius K; Alonso A
    Arch Virol; 2005 Feb; 150(2):231-46. PubMed ID: 15503216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The E5 protein of HPV-6, but not HPV-16, associates efficiently with cellular growth factor receptors.
    Conrad M; Goldstein D; Andresson T; Schlegel R
    Virology; 1994 May; 200(2):796-800. PubMed ID: 7909971
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human papillomavirus type 11 and 16 E5 represses p21(WafI/SdiI/CipI) gene expression in fibroblasts and keratinocytes.
    Tsao YP; Li LY; Tsai TC; Chen SL
    J Virol; 1996 Nov; 70(11):7535-9. PubMed ID: 8892872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Virological and carcinogenic aspects of HPV].
    Prétet JL; Charlot JF; Mougin C
    Bull Acad Natl Med; 2007 Mar; 191(3):611-23; discussion 623. PubMed ID: 18072657
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transformation of mortal human fibroblasts and activation of a growth inhibitory pathway by the bovine papillomavirus E5 oncoprotein.
    Petti LM; Ray FA
    Cell Growth Differ; 2000 Jul; 11(7):395-408. PubMed ID: 10939593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human papillomavirus type 16 E6 and E7 oncoproteins upregulate c-IAP2 gene expression and confer resistance to apoptosis.
    Yuan H; Fu F; Zhuo J; Wang W; Nishitani J; An DS; Chen IS; Liu X
    Oncogene; 2005 Jul; 24(32):5069-78. PubMed ID: 15856013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HPV-16 E5 oncoprotein upregulates lipid raft components caveolin-1 and ganglioside GM1 at the plasma membrane of cervical cells.
    Suprynowicz FA; Disbrow GL; Krawczyk E; Simic V; Lantzky K; Schlegel R
    Oncogene; 2008 Feb; 27(8):1071-8. PubMed ID: 17704805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The bovine papillomavirus oncoprotein E5 retains MHC class I molecules in the Golgi apparatus and prevents their transport to the cell surface.
    Marchetti B; Ashrafi GH; Tsirimonaki E; O'Brien PM; Campo MS
    Oncogene; 2002 Nov; 21(51):7808-16. PubMed ID: 12420217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The human papillomavirus type 16 E5 protein alters vacuolar H(+)-ATPase function and stability in Saccharomyces cerevisiae.
    Briggs MW; Adam JL; McCance DJ
    Virology; 2001 Feb; 280(2):169-75. PubMed ID: 11162831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human papillomavirus type 45 E7 is a transforming protein inducing retinoblastoma protein degradation and anchorage-independent cell cycle progression.
    Morandell D; Rostek U; Bouvard V; Campo-Fernández B; Fiedler M; Jansen-Dürr P; Zwerschke W
    Virology; 2008 Sep; 379(1):20-9. PubMed ID: 18649911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Similarities and differences between the E5 oncoproteins of bovine papillomaviruses type 1 and type 4: cytoskeleton, motility and invasiveness in E5-transformed bovine and mouse cells.
    Tsirimonaki E; Ullah R; Marchetti B; Ashrafi GH; McGarry L; Ozanne B; Campo MS
    Virus Res; 2006 Feb; 115(2):158-68. PubMed ID: 16168512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.